Aldevron

Aldevron Serving the biotech industry with clinical and commercial manufacturing of plasmids, mRNA, and mRNA OUR VALUES
We innovate and advance. We serve. We collaborate.

OUR MISSION
We manufacture biologics to the highest quality, meeting precise client requirements through smart investments and innovation. OUR VISION
We seek to be the partner of choice to provide high-quality plasmid DNA, RNA, proteins, and other biologicals to support our client’s objectives. We make lives better.

---------------------------------------------------------------------------------

-----------------

Aldevron is proud to be part of Danaher. Danaher’s science and technology leadership puts Aldevron’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

The energy carried through earlier today at ICGT in Paris, where our joint ALD / IDT / Cytiva workshop—Accelerating Pers...
05/27/2026

The energy carried through earlier today at ICGT in Paris, where our joint ALD / IDT / Cytiva workshop—Accelerating Personalized CRISPR Therapies—brought together strong engagement around what it takes to advance these programs from concept to clinic.

Great to see the collaboration across teams and hear how others in the field are tackling challenges around speed, control, and scalability in personalized approaches. Sessions like this continue to reinforce how important integrated expertise is as expectations for performance and precision evolve.

If you’re attending ICGT, there’s still time to connect onsite.

Today, we pause to remember.Memorial Day is a time to honor the men and women who gave their lives in service to others....
05/25/2026

Today, we pause to remember.

Memorial Day is a time to honor the men and women who gave their lives in service to others. Their sacrifice continues to shape the freedoms and opportunities we have today.

We recognize the weight of this day and the families and communities who carry it with them.

In observance of Memorial Day, our U.S. offices are closed today (May 25th).

We are heading to ICGT 2026 next week, May 27th and 28th, in France.We will be with our friends at Cytiva and Integrated...
05/22/2026

We are heading to ICGT 2026 next week, May 27th and 28th, in France.

We will be with our friends at Cytiva and Integrated DNA Technologies both at the booth and during our May 27th workshop: Accelerating Personalized CRISPR Therapies. Catch our very own Tim Traynor alongside Abdelilah Mekhloufi (Integrated DNA Technologies) and Martin Rabel (Cytiva).

Don't miss out and make sure to visit us at ICGT to talk all things cell and gene therapies. Learn more about the conference: https://ald.bio/4dWfBgb

05/22/2026

If you are thinking about nonviral approaches for cell engineering, this one is worth adding to your calendar.

We are hosting a Lunch and Learn with Trince in Leiden starting at 8:45 am CET, focused on practical considerations across DNA, RNA, and delivery for gene editing workflows.

Lunch, discussion, and real-world perspectives included.

Learn more and register here:

https://ald.bio/4ujMSb7

Ordering is more seamless for our European customers and now even more capable. You can now place Nanoplasmid orders, in...
05/21/2026

Ordering is more seamless for our European customers and now even more capable.

You can now place Nanoplasmid orders, including gene synthesis, directly through our e‑commerce platform—bringing more of your workflow into a single, streamlined experience. From discovery to pre-clinical research, it’s another step toward simplifying how science moves forward.

👉 Check it out: https://ald.bio/4wH8PCq


Clinical trials are foundational to advancing new therapies and improving patient care.On International Clinical Trials ...
05/20/2026

Clinical trials are foundational to advancing new therapies and improving patient care.

On International Clinical Trials Day, we recognize the researchers, clinicians, and participants whose commitment helps translate scientific discovery into meaningful health outcomes.

The 14th Galenus Workshop is underway, bringing together experts focused on advancing mRNA science and delivery.Work acr...
05/18/2026

The 14th Galenus Workshop is underway, bringing together experts focused on advancing mRNA science and delivery.

Work across process optimization, quality, and scalability continues to push the field forward as expectations for performance and precision grow.

Tomorrow, our very own Nicolò Sacchetti will present a poster titled:
“Impact of dsRNA on cellular viability and reduction of dsRNA in in vitro transcribed mRNA via enzymatic optimization and polishing.”

May 19 | 12:30–12:45

If you’re attending, this is an opportunity to explore how dsRNA mitigation strategies can influence mRNA quality and downstream outcomes.

05/13/2026

Partnerships like this don’t happen overnight and they don’t move forward without real alignment.

At ASGCT, Emma Bjorgum (Aldevron) and Francesca Vitelli (Minaris Advanced Therapies) took a moment to share their excitement. This collaboration is about expanding access to lentiviral plasmids in a way that actually reduces complexity for developers.

The goal is simple: make it easier to move from discovery into the clinic with greater consistency, fewer bottlenecks, and materials that are ready to scale when it matters most.

05/12/2026

Join us tomorrow, May 13, from 12:00–1:15 PM ET for an Aldevron Knowledge Lab session at ASGCT 2026 in Room 213.

From Design to Delivery: A Translational Framework for Non-Viral Gene Editing
This session explores an end-to-end approach for advancing non-viral CRISPR gene editing from concept through clinical application. The discussion will highlight strategies to support both in vivo and ex vivo programs, with a focus on specificity, manufacturability, and regulatory considerations.

Lunch will be provided, and registration is limited.

Learn more and register here:
https://ald.bio/4tGcwWs

Earlier today, at TIDES 2026, Anders Lund shared how RNA analytics must evolve to support tomorrow’s therapies—from stro...
05/12/2026

Earlier today, at TIDES 2026, Anders Lund shared how RNA analytics must evolve to support tomorrow’s therapies—from stronger characterization to better‑informed development decisions. With TIDES continuing tomorrow, discussions around advancing RNA modalities will carry on across the community.

Address

4055 41st Avenue S
Fargo, ND
58104

Alerts

Be the first to know and let us send you an email when Aldevron posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Aldevron:

Share